Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05535140 · ClinicalTrials.gov registry record
A Chatbot-Powered G8 Screening Intervention to Facilitate Referrals to a Comprehensive Geriatric Assessment Among Older Adults With Cancer
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 100
- Enrollment target
NCT05535140: Completed study, sponsored by Thomas Jefferson University.
NCT05535140 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05535140 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
In this prospective quality improvement study, we will develop and evaluate the feasibility and acceptability of an online patient self-reported G8 screening tool which will allow us to efficiently identify G8 positive older cancer patients to be referred to our Senior Adult Oncology Center (SAOC) for a Comprehensive Geriatric Assessment (CGA).
Primary Outcome
To determine the feasibility of implementing an online patient self-reported G8 assessment, on new patients \>65y/o who are scheduled with the medical oncology department.
Interventions
- OTHER G8 Screening Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2024-01-01 |
What the finished NCT05535140 record still lists
NCT05535140 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which G8 Screening Tool is the first listed.
NCT05535140 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05535140 about?
NCT05535140 is a clinical study titled "A Chatbot-Powered G8 Screening Intervention to Facilitate Referrals to a Comprehensive Geriatric Assessment Among Older Adults With Cancer". In this prospective quality improvement study, we will develop and evaluate the feasibility and acceptability of an online patient self-reported G8 screening tool which will allow us to efficiently identify G8 positive older cancer patients to be referred to our Senior Adult Oncology Center (SAOC) f...
What is the current status of trial NCT05535140?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2022-07-01. Estimated completion is 2024-01-01.
What interventions are being tested in trial NCT05535140?
The interventions under investigation include: G8 Screening Tool (OTHER).
Who is sponsoring clinical trial NCT05535140?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI